文献速递头颈介入CT

经皮CT引导下头颈部肿块空芯针活检:单学术机构184例回顾,常见与特殊技术、诊断率及安全性

Percutaneous CT-Guided Core Needle Biopsies of Head and Neck Masses: Review of 184 Cases at a Single Academic Institution, Common and Special Techniques, Diagnostic Yield, and Safety.
PubMed 文献 · AJNR Am J Neuroradiol · 2021-12-09

单中心回顾性研究评估2010年1月1日至2020年10月30日184例经皮CT引导下头颈部病变空芯针活检,初始诊断率93%(171/184),调整后总诊断率91%(167/184),假阴性率2%;不同操作者经验和针径的诊断率相近,仅4例无症状血肿且无需干预,结论认为该技术对浅表和深部病变安全且诊断率高。

要点

  • 184例经皮CT引导头颈部空芯针活检初始诊断率93%,调整后总诊断率91%。
  • 43例原报告「恶性肿瘤阴性」中4例经再活检/切除最终恶性,假阴性率2%。
  • 仅4例无症状血肿且无需干预,操作者经验≤3年与>3年诊断率相近。

核心结论

  • 经皮CT引导空芯针活检对浅表和深部头颈部病变是安全操作且诊断率高。
  • 仔细规划和特殊技术可能增加可经皮穿刺的病变数量,同时尽量减少并发症风险。

研究设计与样本

  • 单中心回顾性研究,纳入2010年1月1日至2020年10月30日经皮CT引导下头颈部病变空芯针活检184例。
  • 记录患者人口学、镇静细节、活检针类型和尺寸、病变位置和大小、入路、患者体位、术前静脉造影、操作者经验年限、并发症和病理结果。
  • 活检由16名经验不等的神经放射科医生完成。

诊断标准与关键数值

  • 初始诊断率93%(171/184);43/184(23%)原报告「恶性肿瘤阴性」中4例经再活检/切除最终恶性,假阴性率2%,调整后总诊断率167/184(91%)。
  • 操作者经验≤3年诊断率91%(64/70),>3年诊断率90%(103/114)。
  • 病变>10 mm诊断率93%(155/166)。
  • 按活检针径诊断率:20 G为81%(13/16),18 G为93%(70/75),16 G为90%(64/71),14 G为91%(20/22)。

临床应用与阅片要点

  • 经皮CT引导空芯针活检可用于浅表和深部头颈部病变,原文结论认为该操作安全且诊断率高。
  • 原文指出仔细规划和特殊技术可能增加可经皮穿刺的病变数量,同时尽量减少并发症风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Percutaneous CT-guided core needle biopsies of head and neck lesions can be safely performed with vigilant planning. This largest-to-date single-center retrospective study evaluates multiple approaches with consideration of special techniques and examines the histopathologic yield.

MATERIALS AND METHODS: Retrospective review of CT-guided core biopsies of head and neck lesions from January 1, 2010, to October 30, 2020, was performed. We recorded the following: patient demographics, sedation details, biopsy needle type and size, lesion location and size, approach, patient positioning, preprocedural intravenous contrast, proceduralists' years of experience, complications, and pathology results.

RESULTS: One hundred eighty-four CT-guided core biopsies were evaluated. The initial diagnostic yield was 93% (171/184). However, of 43/184 (23%) originally "negative for malignancy" biopsies, 4 were eventually positive for malignancy via rebiopsy/excision, resulting in a 2% false-negative rate and an adjusted total diagnostic yield of 167/184 (91%). Biopsies were performed by 16 neuroradiologists with variable experience. The diagnostic yield was essentially the same: 91% (64/70) for proceduralists with ≤3 years' experience, and 90% (103/114) with >3 years' experience. The diagnostic yield was 93% (155/166) for lesions of >10 mm. The diagnostic yield per biopsy needle gauge was the following: 20 ga, 81% (13/16); 18 ga, 93% (70/75); 16 ga, 90% (64/71); and 14 ga, 91% (20/22). There were 4 asymptomatic hematomas, with none requiring intervention.

CONCLUSIONS: Percutaneous CT-guided core needle biopsies are safe procedures for superficial and deep head and neck lesions with a high diagnostic yield. Careful planning and special techniques may increase the number of lesions accessible percutaneously while minimizing the risk of complications.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Jordan, Shlapak, Benson, et al. Percutaneous CT-Guided Core Needle Biopsies of Head and Neck Masses: Review of 184 Cases at a Single Academic Institution, Common and Special Techniques, Diagnostic Yield, and Safety. AJNR Am J Neuroradiol. 2021. PMID: 34887246. doi:10.3174/ajnr.A7348

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。